Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 18 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-18-2021-3

Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 18, 2021, titled "Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases